Study analysis · AIDS and Behavior · 2025
In a tiny HIV study, 8 weeks of strength training improved thinking and depression—but didn't budge BDNF, challenging a popular brain-exercise theory.
In a small study of 20 people with HIV, those who did 8 weeks of resistance training improved their thinking test and depression scores compared to those who didn't, but their blood levels of a brain-health protein called BDNF didn't change.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
In simple terms
This study is a randomized controlled trial, which is a strong type of study for testing cause and effect. People were randomly split into exercise and no-exercise groups, so we can be somewhat confident that the exercise caused the improvements. However, because we only have a short summary and few people, we can't be completely certain.
What’s the bottom line?
A small study in people with HIV split them into two groups: one did eight weeks of resistance training and one did not. The training group did better on a thinking test and had fewer depression symptoms, but their blood BDNF levels did not change.
How strong is this study?
The study is small (only 20 people) and we don't know if the people or researchers knew who was in which group. Also, we only have the abstract, not the full details. So while the results are interesting, we should be cautious about trusting them completely.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
59 / 100
- Randomization+20/20
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=20)+1.9/20
- Follow-up+10/10
100 / 100
46 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 552 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. Randomized controlled design can support causal inference, but abstract-only limits verification of allocation concealment, blinding, and protocol adherence. Small sample (n=20) and short duration reduce precision and generalizability. Blinding unknown may introduce performance/detection bias.
COI Unknown
Could not determine conflict of interest status
No conflicts of interest or funding information are provided in the abstract, so the potential for bias cannot be assessed.
The provided text is only an abstract and lacks a COI declaration, funding statement, or author affiliations. A full article review is needed for a complete COI assessment.
Key takeaways
- 01
20 people with HIV: 11 did eight weeks of resistance training, 9 did not.
- 02
Depression scores changed by about +1.6 points in the control group and -3.2 points in the training group (absolute difference about 4.7 BDI points).
- 03
Thinking test improved in the training group.
- 04
BDNF levels did not significantly change (P > 0.05).
- 05
This was a very small study, so the results are uncertain.
- 06
The depression-score difference was about 4.7 points on the BDI scale, but the study did not report absolute risk or how many people improved enough to notice.
- 07
No absolute risk increase or decrease was reported in the abstract.
- 08
The BDNF finding was null.
Practical takeaways
People with HIV could discuss adding resistance training with their healthcare provider as a potential way to support mood and cognition.
Based on a very small abstract-only RCT (n=20); full text unavailable, no effect sizes or confidence intervals reported. This is not medical advice.
low confidenceDon't assume blood BDNF is a reliable marker of exercise's brain benefits—this study found no BDNF change despite cognitive and mood improvements.
Abstract only; blood BDNF may not reflect brain BDNF; small sample; other mechanisms likely.
low confidenceWhy this study matters
Strength training linked to better mood in HIV
In the abstract, the Beck Depression Inventory change was +1.56 ± 2.46 in the control group (n=9) versus -3.18 ± 1.66 in the training group (n=11), an absolute between-group difference of about 4.7 BDI points. The abstract reports P > 0.001 (as written; likely a typo for P < 0.001, but full text is unavailable to verify).
Depression is common in people living with HIV, and a non-drug option like strength training could be appealing if it works.
Thinking skills also improved
The abstract states resistance training promoted significant improvements in cognitive domains measured by the Stroop Test. However, effect sizes and absolute risks for cognitive outcomes were not reported in the abstract.
Cognitive impairment is a major aging-related concern for people with HIV, so any low-cost intervention is worth exploring.
BDNF didn't change—surprising null
Circulating BDNF levels showed no significant change (P > 0.05), even though cognition and depression improved. This challenges the common assumption that exercise benefits the brain mainly by boosting BDNF.
Many people believe exercise's brain benefits are all about BDNF. This study suggests other mechanisms may be at play—at least in this context.
Very small sample limits confidence
Only 20 people were randomized (9 control, 11 training; 12 men, 8 women). No effect sizes or confidence intervals were reported in the abstract.
Small studies can show large effects by chance. Knowing this helps audiences judge headlines responsibly.
HIV, aging, and mental health context
The abstract notes that increased life expectancy from antiretroviral therapy has led to more aging-related and mental health comorbidities in people with HIV, including cognitive impairment and depression.
As people with HIV live longer, managing brain and mood health becomes a bigger priority.
Want the whole report?
Detailed mode opens the full scientific breakdown — every score component, the methodology, conflicts of interest, the evidence analysis behind each claim, and the raw study data.
Overview
What the study found
The study in plain English — the bottom line, every takeaway we extracted, and what to do with them.
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A small study in people with HIV split them into two groups: one did eight weeks of resistance training and one did not. The training group did better on a thinking test and had fewer depression symptoms, but their blood BDNF levels did not change.
Research results
20 people with HIV: 11 did eight weeks of resistance training, 9 did not. Depression scores changed by about +1.6 points in the control group and -3.2 points in the training group (absolute difference about 4.7 BDI points). Thinking test improved in the training group. BDNF levels did not significantly change (P > 0.05).
What this means - more context
This was a very small study, so the results are uncertain. The depression-score difference was about 4.7 points on the BDI scale, but the study did not report absolute risk or how many people improved enough to notice. No absolute risk increase or decrease was reported in the abstract. The BDNF finding was null.
To investigate the effects of eight weeks of resistance training on cognitive function and depression status in people with HIV.
In this small randomized controlled trial, eight weeks of resistance training was reported to significantly improve cognitive function and reduce depressive symptoms in people with HIV. The Beck Depression Inventory change was +1.56 +/- 2.46 in the control group versus -3.18 +/- 1.66 in the training group, an absolute between-group difference of about 4.7 BDI points. Circulating BDNF levels did not change significantly (P > 0.05).
Methods Used
Randomized controlled trial; 20 subjects (12 men and 8 women) with HIV randomized to control (n=9) or resistance training (n=11); cognitive function (Stroop Test), depression status (Beck Depression Inventory), and plasma BDNF levels assessed before and after eight weeks of resistance training.
Main Finding
The abstract reports that eight weeks of resistance training improved cognitive function and depression status in people with HIV without changing circulating BDNF levels. Depression: BDI change was +1.56 +/- 2.46 in the control group versus -3.18 +/- 1.66 in the training group, an absolute difference of about 4.7 BDI points. Cognitive function effect sizes and absolute risks were not reported in the abstract; BDNF showed no significant change (P > 0.05).
Confidence Level
Limited - based on abstract only, full methodology not available; very small sample (n=20), no effect sizes or confidence intervals reported.
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Very small sample size (n=20; 9 control, 11 training)
- •Effect sizes and confidence intervals not reported in abstract
Practical Takeaways
People with HIV could discuss adding resistance training with their healthcare provider as a potential way to support mood and cognition.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 552 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
Moderate probability
on the GRADE evidence scale
This study is a randomized controlled trial, which is a strong type of study for testing cause and effect. People were randomly split into exercise and no-exercise groups, so we can be somewhat confident that the exercise caused the improvements. However, because we only have a short summary and few people, we can't be completely certain.
Strengths
- Randomized controlled trial design
- Presence of control group
- Objective outcome measures (Stroop Test, Beck Depression Inventory, plasma BDNF)
Weaknesses
- Full methodology not available - based on abstract only
- Small sample size (n=20)
- Blinding not reported/unknown
Methodology
Evidence Keywords
Statistical Reporting
Not medical advice. For informational purposes only. Always consult a healthcare professional. Terms
A small study in people with HIV split them into two groups: one did eight weeks of resistance training and one did not. The training group did better on a thinking test and had fewer depression symptoms, but their blood BDNF levels did not change.
Research results
20 people with HIV: 11 did eight weeks of resistance training, 9 did not. Depression scores changed by about +1.6 points in the control group and -3.2 points in the training group (absolute difference about 4.7 BDI points). Thinking test improved in the training group. BDNF levels did not significantly change (P > 0.05).
What this means - more context
This was a very small study, so the results are uncertain. The depression-score difference was about 4.7 points on the BDI scale, but the study did not report absolute risk or how many people improved enough to notice. No absolute risk increase or decrease was reported in the abstract. The BDNF finding was null.
To investigate the effects of eight weeks of resistance training on cognitive function and depression status in people with HIV.
In this small randomized controlled trial, eight weeks of resistance training was reported to significantly improve cognitive function and reduce depressive symptoms in people with HIV. The Beck Depression Inventory change was +1.56 +/- 2.46 in the control group versus -3.18 +/- 1.66 in the training group, an absolute between-group difference of about 4.7 BDI points. Circulating BDNF levels did not change significantly (P > 0.05).
Methods Used
Randomized controlled trial; 20 subjects (12 men and 8 women) with HIV randomized to control (n=9) or resistance training (n=11); cognitive function (Stroop Test), depression status (Beck Depression Inventory), and plasma BDNF levels assessed before and after eight weeks of resistance training.
Main Finding
The abstract reports that eight weeks of resistance training improved cognitive function and depression status in people with HIV without changing circulating BDNF levels. Depression: BDI change was +1.56 +/- 2.46 in the control group versus -3.18 +/- 1.66 in the training group, an absolute difference of about 4.7 BDI points. Cognitive function effect sizes and absolute risks were not reported in the abstract; BDNF showed no significant change (P > 0.05).
Confidence Level
Limited - based on abstract only, full methodology not available; very small sample (n=20), no effect sizes or confidence intervals reported.
Study Flags
Red Flags
- •Full text not available - methodology details cannot be verified
- •Very small sample size (n=20; 9 control, 11 training)
- •Effect sizes and confidence intervals not reported in abstract
Practical Takeaways
People with HIV could discuss adding resistance training with their healthcare provider as a potential way to support mood and cognition.
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 552 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
Human RCT
Subject
Moderate probability
on the GRADE evidence scale
This study is a randomized controlled trial, which is a strong type of study for testing cause and effect. People were randomly split into exercise and no-exercise groups, so we can be somewhat confident that the exercise caused the improvements. However, because we only have a short summary and few people, we can't be completely certain.
Strengths
- Randomized controlled trial design
- Presence of control group
- Objective outcome measures (Stroop Test, Beck Depression Inventory, plasma BDNF)
Weaknesses
- Full methodology not available - based on abstract only
- Small sample size (n=20)
- Blinding not reported/unknown
Methodology
Evidence Keywords
Statistical Reporting
Scoring
How strong is this study?
The study is small (only 20 people) and we don't know if the people or researchers knew who was in which group. Also, we only have the abstract, not the full details. So while the results are interesting, we should be cautious about trusting them completely.
0 / 100
- COI disclosureconflicts of interest not disclosed
- Data availabilitydata not shared
- Code availabilitycode not shared
59 / 100
- Randomization+20/20
- Blindingblinding unclear
- Control group+15/15
- Sample size (n=20)+1.9/20
- Follow-up+10/10
100 / 100
46 / 100
- P-values+15/15
- Effect sizeno effect size reported
- Confidence intervalsno confidence intervals
- Pre-registration+15/15
Each component is scored out of 100 and then capped by the study design — a case series cannot reach the ceiling a randomised trial can, however well it is reported.
Where it sits
RCT reviewsReviews of RCTs (Meta-analyses)
Max 100Randomized TrialsRandomized Trials
Max 90Reviews of Cohort StudiesReviews of Cohort Studies
Max 85Cohort StudiesCohort Studies
Max 72Reviews of Case-Control StudiesReviews of Case-Control Studies
Max 63Case-Control StudiesCase-Control Studies
Max 58Cross-Sectional & Case SeriesCross-Sectional & Case Series
Max 50Expert OpinionExpert Opinion
Max 552 / 100
Probability of being correct
Participants are randomly assigned to treatment or control groups, minimizing bias. The gold standard for testing whether an intervention causes an effect.
This design can establish causation. Randomized controlled design can support causal inference, but abstract-only limits verification of allocation concealment, blinding, and protocol adherence. Small sample (n=20) and short duration reduce precision and generalizability. Blinding unknown may introduce performance/detection bias.
COI Unknown
Could not determine conflict of interest status
No conflicts of interest or funding information are provided in the abstract, so the potential for bias cannot be assessed.
The provided text is only an abstract and lacks a COI declaration, funding statement, or author affiliations. A full article review is needed for a complete COI assessment.
Standing
The people behind it
The researchers who wrote the study this analysis is built on.
Authored by
8 researchersIf this is your work, this is how we attribute it on Fit Body Science. Dayane Cristina de Souza is listed as the lead author.